Professional Documents
Culture Documents
BASAVATARAKAMINDO-AMERICANASAVATA
& RESEARCH
CANCER HOSPITAL Basavataraka INSTITUTE Foundation
Promoted by Ramarao Memorial Cancer
Smt. Nandamuri
Cancer Organisation
NABH &IndoAmerican
India
MC-2050 Banjara Hills, Hyderabad 500034,
Road No 10,
Quality matters in Cancer Care Phones: 91-40-2355 1235/23607944, Fax: 91-40-2354 2120 INDO-AMERICAN
E-Mail: info@induScancer.com www.induscancer.com N T I i MK NTE
BIACHRI/ MRF/DS 16
DISCHARGE SUMMARY ()
IPMR2101146
Name Mrs D LALITHA Patient ID MRA165275 Visit 1D
: WARD22-6/Ward
Age 60 Yrs Gender Female Bed/Ward 22
Consultant(s):
Dr KRISHNA MOHAN MVT DNB(Med),DM,MNAMS,PDCR
Final Diagnosis:
Relapsed Ca. Ovary stage 4 (2nd relapse) PFI 20 months
Clinical History:
A 59 years old female is diagnosed as Ca. Ovary, stage IV (second relapse). She is planned for weekly Padi +Carbo & 3 weekly
Bevacizumab. Postcyde 1/ day 1, she had mucositis, which was treated symptomatically.
Admitted for oycle 2/ Day 15 chemotherapy.
Summary of Treatment:
Cycle 2/ Day 15.
Inj Paditaxel 100mg
Inj Carboplatin 150mg
Condition on Discharge: Stable.
Discharge Advice:
1. Tab. Pan 40mg once daily x 7 days
2. Tab. Zofer 4mg twice daily x 3 days
3. Cap. Becosules once daily x 20 days
4. Tab. Ursocol 300mg 1-1-1x 5 days
5. Tab. Ultracet 1-1 x 5 days
6.Tab Zolfresh 5mg PO H/s for insomnia
7. Review on 27.01.2021for cycle 3/ Day 1 chemotherapy with CBP, Sr. Creatinine and Sr. Blirubin reports.
Food/ Drug Interaction: As explained.
Diet Advice: As explained.
CongulkartMadoal n c o t o i
Contact No:
i n r-i ierir
8 s a v a l a r a a n m
Typed Date :13/01/2021 Typed By: Ms LEELAVATHI G Printed By: LEELAVATHI G CanoriHo:ERer
R d No.1, F
HYDERAE